A new, community-wide trial in Salford will launch imminently to assess the benefits of repeat population testing for Covid-19
The trial is part of a new £500 million funding package that will be invested in next generation testing technology and increased testing capacity, the Health and Social Care Secretary announced today.
Saliva-based testing will be used to test the community in Salford, Greater Manchester, in the coming weeks. Working with Salford Council, local health partners and voluntary and community-based networks, some people living in Salford will be invited for a weekly test. The pilot will explore how regular repeat testing can be made as accessible as possible and will inform how to scale community testing across the country.
The pilot will begin with a select number of participants and up to 250 tests a day, to be scaled to the whole area. Initially, the pilot will focus on a specific high footfall location in the city, which includes retail, public services, transport and faith spaces. Weekly tests will help to identify cases early, including for those with no or minor symptoms, allowing those testing positive to self-isolate.
By using this cutting-edge technology to widely roll out rapid tests, chains of transmission will be broken almost immediately by delivering on-the-spot results. Successful trials will then be expanded and rolled out more widely.
The funding will also be used to further extend capacity for existing polymerase chain reaction (PCR) testing across the country. All positive results will be passed to the NHS Test and Trace system, to trace contacts, prevent further transmission, and save lives.
Health and Social Care Secretary Matt Hancock said:
Testing is a vital line of defence in combating this pandemic. Over the past 6 months we have built almost from scratch one of the biggest testing systems in the world. We need to use every new innovation at our disposal to expand the use of testing, and build the mass testing capability that can help suppress the virus and enable more of the things that make life worth living. We are backing innovative new tests that are fast, accurate and easier to use and will maximise the impact and scale of testing, helping us to get back to a more normal way of life.